Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered green red network_comparison
Results: HTML CSV LaTeX Showing element 2025 to 2074 of 3228 in total
Value Type  : Ranked
Network Comparison Type  : Divided
Interaction Map  : High confidence
Filtered  : 1
Rank
description
green
red
network_comparison
2025 alanine aminotransferase (ec 2.6.1.2) (glutamic--pyruvic transaminase) (gpt) (glutamic--alanine transaminase). [swissprot;acc:p24298] 191.668 189.987 1.00885
2026 vacuolar protein sorting 11 (hvps11) (pp3476). [swissprot;acc:q9h270] 213.663 215.553
2027 lin-7 homolog c; lin-7 protein 3. [refseq;acc:nm_018362] 223.041 225.015
2028 vacuolar protein sorting 33a (hvps33a). [swissprot;acc:q96ax1] 213.663 215.553
2029 cytoplasmic cysteine conjugate-beta lyase; glutamine-phenylpyruvate aminotransferase. [refseq;acc:nm_004059] 191.677 189.999 1.00883
2030 alanine aminotransferase 2; glutamic-pyruvate transaminase 2. [refseq;acc:nm_133443]
2031 traf and tnf receptor-associated protein; ets1-associated protein 2. [refseq;acc:nm_016614] 216.562 218.466 1.00879
2032 f-actin capping protein alpha-3 subunit (capz alpha-3) (germ cell- specific protein 3). [swissprot;acc:q96kx2] 213.46 215.322 1.00872
2033 f-actin capping protein beta subunit (capz beta). [swissprot;acc:p47756]
2034 centaurin beta 5 (cnt-b5). [swissprot;acc:q96p50] 220.812 218.919 1.00865
2035 centaurin beta 2 (cnt-b2). [swissprot;acc:q15057]
2036 lamin b1. [swissprot;acc:p20700] 220.813
2037 centaurin beta 1 (cnt-b1). [swissprot;acc:q15027] 220.812
2038 lamin a/c (70 kda lamin). [swissprot;acc:p02545] 220.811 218.92 1.00864
2039 acetyl-coenzyme a synthetase, cytoplasmic (ec 6.2.1.1) (acetate--coa ligase) (acyl-activating enzyme) (acetyl-coa synthetase) (acs) (acecs). [swissprot;acc:q9nr19] 192.191 190.551 1.00861
2040 brachyury protein (t protein). [swissprot;acc:o15178] 208.803 210.586 1.00854
2041 ataxin-1 ubiquitin-like interacting protein. [refseq;acc:nm_020131] 195.141 196.808
2042 t-box transcription factor tbx19 (t-box protein 19). [swissprot;acc:o60806] 208.803 210.586
2043 ubiquilin 1 isoform 1. [refseq;acc:nm_013438] 195.173 196.837 1.00853
2044 adapter-related protein complex 3 beta 1 subunit (beta-adaptin 3a) (ap-3 complex beta-3a subunit) (beta-3a-adaptin). [swissprot;acc:o00203] 198.24 199.928 1.00851
2045 ny-ren-24 antigen (fragment). [sptrembl;acc:q9y5a4]
2046 adapter-related protein complex 3 beta 2 subunit (beta-adaptin 3b) (ap-3 complex beta-3b subunit) (beta-3b-adaptin) (neuron-specific vesicle coat protein beta-nap). [swissprot;acc:q13367]
2047 solute carrier family 2, facilitated glucose transporter, member 6 (glucose transporter type 6) (glucose transporter type 9). [swissprot;acc:q9ugq3] 226.003 224.124 1.00838
2048 solute carrier family 2, facilitated glucose transporter, member 8 (glucose transporter type 8) (glucose transporter type x1). [swissprot;acc:q9ny64]
2049 translation initiation factor eif-2b beta subunit (eif-2b gdp-gtp exchange factor) (s20i15) (s20iii15). [swissprot;acc:p49770] 222.634 220.787 1.00837
2050 sh3 domain-binding glutamic acid-rich protein (sh3bgr protein) (21- glutamic acid-rich protein) (21-garp). [swissprot;acc:p55822] 216.981 218.79 1.00834
2051 oxidation resistance 1. [refseq;acc:nm_181354]
2052 ornithine decarboxylase antizyme inhibitor. [swissprot;acc:o14977] 205.95 207.667
2053 lats, large tumor suppressor, homolog 2; lats (large tumor suppressor, drosophila) homolog 2. [refseq;acc:nm_014572] 216.981 218.79
2054 ornithine decarboxylase-like protein (ec 4.1.1.17) (odc-paralogue) (odc-p). [swissprot;acc:q96a70] 205.948 207.665
2055 dymeclin. [refseq;acc:nm_017653] 216.981 218.79
2056 sh3 domain-binding glutamic acid-rich-like protein. [swissprot;acc:o75368]
2057 lats homolog 1. [refseq;acc:nm_004690]
2058 sh3 domain-binding glutamic acid-rich-like protein 2 (fovea-associated sh3 domain binding protein). [swissprot;acc:q9ujc5]
2059 nuclear receptor coactivator 7; estrogen receptor associated protein 140 kda. [refseq;acc:nm_181782]
2060 dj132f21.2 (contains a novel protein similar to the l82e from drosophila) (fragment). [sptrembl;acc:q9h125]
2061 tbc1 domain family protein c22orf4-like (fragment). [swissprot;acc:q9nu19]
2062 tbc1 domain family protein c22orf4. [swissprot;acc:q8wua7]
2063 ornithine decarboxylase (ec 4.1.1.17) (odc). [swissprot;acc:p11926] 205.923 207.638 1.00833
2064 aminoadipate-semialdehyde synthase; lysine-ketoglutarate reductase /saccharopine dehydrogenase; lysine-2-oxoglutarate reductase; aminoadipic semialdehyde synthase. [refseq;acc:nm_005763] 205.939 207.655
2065 ubiquitin-conjugating enzyme e2 n (ec 6.3.2.19) (ubiquitin-protein ligase n) (ubiquitin carrier protein n) (ubc13) (bendless-like ubiquitin conjugating enzyme). [swissprot;acc:q16781] 212.561 214.328 1.00831
2066 proliferating cell nuclear antigen (pcna) (cyclin). [swissprot;acc:p12004] 231.001 229.102 1.00829
2067 adenylosuccinate lyase (ec 4.3.2.2) (adenylosuccinase) (asl) (asase). [swissprot;acc:p30566] 191.639 193.226 1.00828
2068 fas apoptotic inhibitory molecule. [refseq;acc:nm_018147] 222.61 220.8 1.0082
2069 dual specificity mitogen-activated protein kinase kinase 1 (ec 2.7.1.-) (map kinase kinase 1) (mapkk 1) (erk activator kinase 1) (mapk/erk kinase 1) (mek1). [swissprot;acc:q02750] 215.807 217.555 1.0081
2070 rac gtpase activating protein 1; gtpase activating protein. [refseq;acc:nm_013277] 225.008 223.199
2071 similar to kinase suppressor of ras (fragment). [sptrembl;acc:q8ivt5] 215.807 217.555
2072 dual specificity mitogen-activated protein kinase kinase 2 (ec 2.7.1.-) (map kinase kinase 2) (mapkk 2) (erk activator kinase 2) (mapk/erk kinase 2) (mek2). [swissprot;acc:p36507]
2073 topoisomerase-related function protein 4-2. [refseq;acc:nm_022447] 227.433 229.267 1.00806
2074 dna polymerase gamma subunit 1 (ec 2.7.7.7) (mitochondrial dna polymerase catalytic subunit) (polg-alpha). [swissprot;acc:p54098] 214.599 216.324 1.00804

Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/